Skip to content

Dr. Sofie De Smet

Active Private limited companyfounded 2023active for 3 yearsSint-Arnolduslaan 11, 8200 BrugesKBO/BCE: BE 0800.867.038

Lifetime

3 annual accounts with figures on one time axis
peak of €33,631 in 2025
€33,631▲ 12.1%
peak of €26,278 in 2025
€26,278▲ 16.9%
peak of €46,599 in 2024
€2,876▼ 93.8%
€37,443▲ 143%
Board1 name since 2023
1 director
Documentsfilings and deeds
06-08-20266 days late
2025micro format
Gross margin from €29,991 to €33,631Dividend €70,000Equity from €46,599 to €2,876Debts from €15,429 to €37,443Cash from €61,305 to €38,011

Key points

from the 2025 annual accounts

Equity

€2,876 ▼ 93.8%
46,5992024+26,278Profit-70,000Dividend2,8762025

Dr. Sofie De Smet paid out €70,000 in dividends. That is 266% of the 2025 profit.

Turnover

≈ €100,000 estimated

The micro format states no turnover.

Debts

€37,443 93% of the balance sheet
Suppliers 0%Taxes and wages 22%Other 78%

Liquidity

1.08 was 4.02 in 2024

Short-term debts rose from €15,429 to €37,443.

Filings

3 annual accounts 2 late
AprilJune31 JulyOctober202320242025

The 2023 accounts came in latest, 7 days after the end of the period.

Position in the sector

€2,876

Less equity than 93% of companies in human health. Sector median €125,219 · 21,370 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,155 companies had the same profile as Dr. Sofie De Smet has now. Each dot stands for 6 companies, two years later.

94.1%
were still trading
2.8%
stopped another way
3.0%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,155 companies, not a prediction for Dr. Sofie De Smet. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 18-04-2023
  • 2,500 sharesdeed of 20-04-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0800867038
Incorporation Founding capital of €2,500, 2,500 shares · Founded by · appointed as director · published on 20-04-2023 · Gazette deed
First establishment Sint-Arnolduslaan 11, Bruges
All 7 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Sofie De Smet Bruges €40,320 €33,631 7.1% -
MB MED Trooz €40,281 €33,793 74.5% -
Dr. Esthelle Colle Zedelgem €43,547 €35,905 73.0% -
Dr. Hanne Debevere Bruges €44,063 €38,734 73.7% -
GIRISHYA Eghezée €37,493 €28,937 -53.5% -
CAVASTA MEDICAL Profondeville €39,713 €28,617 83.8% -
Dr. Chloé Grossen Schaerbeek €33,189 €34,440 9.0% -

These companies have the same main activity as Dr. Sofie De Smet: general medical practice (NACE 86210). They are comparable in size and age: total assets between €33,200 and €44,100, founded between 2022 and 2024.

Official details

Source: KBO
Status
Active since 18-04-2023Normal situation
Activity
General medical practiceNACE 86210and 1 other
Establishment unit
2.344.201.5728200 Bruges, since 18-04-2023
Financial year end
31 December
Peppol
Reachable since 07-08-2025
Company details

Annual accounts 2025

€40,320▼ 35.0%
Filing
Filed on 06-08-2026
Financials

Insights on Dr. Sofie De Smet

Dr. Sofie De Smet files the micro format. That format states no turnover. The gross margin rose from €29,370 in 2023 to €33,631 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Sofie De Smet

What is the company number of Dr. Sofie De Smet?
The company number of Dr. Sofie De Smet is 0800.867.038. The VAT number is the same number with BE in front: BE 0800.867.038.
Where is Dr. Sofie De Smet based?
The registered office is at Sint-Arnolduslaan 11, 8200 Bruges.Company details
What does Dr. Sofie De Smet do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Sofie De Smet?
Dr. Sofie De Smet is a private limited company (BV).
When was Dr. Sofie De Smet founded?
Dr. Sofie De Smet was founded on 18-04-2023.
Is Dr. Sofie De Smet still active?
Yes, Dr. Sofie De Smet is an active enterprise in the KBO register.
What is the turnover of Dr. Sofie De Smet?
The turnover in financial year 2025 is ≈ €100,000. This figure is estimated from the gross margin of €33,631 and 47 comparable companies (NACE 86). It probably lies between €74,000 and €150,000.Financials
Is Dr. Sofie De Smet profitable?
In financial year 2025, Dr. Sofie De Smet made a profit of €26,278.
Where can I find the annual accounts of Dr. Sofie De Smet?
Dr. Sofie De Smet filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Sofie De Smet due?
Dr. Sofie De Smet must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.